Found: 64
Select item for more details and to access through your institution.
Brain Region-Specific Differences in Amyloid-β Plaque Composition in 5XFAD Mice.
- Published in:
- Life (2075-1729), 2023, v. 13, n. 4, p. 1053, doi. 10.3390/life13041053
- By:
- Publication type:
- Article
Synergistic Effect on Neurodegeneration by N-Truncated Aβ<sub>4-42</sub> and Pyroglutamate Aβ<sub>3-42</sub> in a Mouse Model of Alzheimer's Disease.
- Published in:
- Frontiers in Aging Neuroscience, 2018, p. 1, doi. 10.3389/fnagi.2018.00064
- By:
- Publication type:
- Article
Evaluation of cerebrospinal fluid glycoprotein NMB (GPNMB) as a potential biomarker for Alzheimer's disease.
- Published in:
- Alzheimer's Research & Therapy, 2021, v. 13, n. 1, p. 1, doi. 10.1186/s13195-021-00828-1
- By:
- Publication type:
- Article
Evaluation of cerebrospinal fluid glycoprotein NMB (GPNMB) as a potential biomarker for Alzheimer's disease.
- Published in:
- Alzheimer's Research & Therapy, 2021, v. 13, n. 1, p. 1, doi. 10.1186/s13195-021-00828-1
- By:
- Publication type:
- Article
Is plasma amyloid-β 1–42/1–40 a better biomarker for Alzheimer's disease than AβX–42/X–40?
- Published in:
- Fluids & Barriers of the CNS, 2022, v. 19, n. 1, p. 1, doi. 10.1186/s12987-022-00390-4
- By:
- Publication type:
- Article
Axonal degeneration in an Alzheimer mouse model is PS1 gene dose dependent and linked to intraneuronal Aβ accumulation.
- Published in:
- Frontiers in Aging Neuroscience, 2014, v. 6, p. 1, doi. 10.3389/fnagi.2014.00139
- By:
- Publication type:
- Article
Blood plasma biomarkers for Alzheimer's disease: Aβ1–42/1–40 vs. AβX–42/X–40.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2024, v. 62, n. 2, p. e56, doi. 10.1515/cclm-2023-0990
- By:
- Publication type:
- Article
Blood plasma biomarkers for Alzheimer's disease: Aβ1–42/1–40 vs. AβX–42/X–40.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2024, v. 62, n. 2, p. e56, doi. 10.1515/cclm-2023-0990
- By:
- Publication type:
- Article
Effects of Long-Term Environmental Enrichment on Anxiety, Memory, Hippocampal Plasticity and Overall Brain Gene Expression in C57BL6 Mice.
- Published in:
- Frontiers in Molecular Neuroscience, 2016, p. 1, doi. 10.3389/fnmol.2016.00062
- By:
- Publication type:
- Article
A novel interface between the N-terminal and coiled-coil domain of STAT1 functions in an auto-inhibitory manner.
- Published in:
- Cell Communication & Signaling, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12964-023-01124-1
- By:
- Publication type:
- Article
Glycoprotein NMB: a novel Alzheimer's disease associated marker expressed in a subset of activated microglia.
- Published in:
- Acta Neuropathologica Communications, 2018, v. 6, n. 1, p. N.PAG, doi. 10.1186/s40478-018-0612-3
- By:
- Publication type:
- Article
The presubiculum is preserved from neurodegenerative changes in Alzheimer's disease.
- Published in:
- Acta Neuropathologica Communications, 2018, v. 6, n. 1, p. N.PAG, doi. 10.1186/s40478-018-0563-8
- By:
- Publication type:
- Article
Deposition of C-terminally truncated Aβ species Aβ37 and Aβ39 in Alzheimer's disease and transgenic mouse models.
- Published in:
- Acta Neuropathologica Communications, 2016, v. 4, p. 1, doi. 10.1186/s40478-016-0294-7
- By:
- Publication type:
- Article
Detection and quantification of Aβ−3–40 (APP669‐711) in cerebrospinal fluid.
- Published in:
- Journal of Neurochemistry, 2022, v. 160, n. 5, p. 578, doi. 10.1111/jnc.15571
- By:
- Publication type:
- Article
The metalloprotease ADAMTS4 generates N-truncated Aβ4-x species and marks oligodendrocytes as a source of amyloidogenic peptides in Alzheimer's disease.
- Published in:
- Acta Neuropathologica, 2019, v. 137, n. 2, p. 239, doi. 10.1007/s00401-018-1929-5
- By:
- Publication type:
- Article
Phosphorylation of the amyloid β-peptide at Ser26 stabilizes oligomeric assembly and increases neurotoxicity.
- Published in:
- Acta Neuropathologica, 2016, v. 131, n. 4, p. 525, doi. 10.1007/s00401-016-1546-0
- By:
- Publication type:
- Article
Focusing the amyloid cascade hypothesis on N-truncated Abeta peptides as drug targets against Alzheimer's disease.
- Published in:
- Acta Neuropathologica, 2014, v. 127, n. 6, p. 787, doi. 10.1007/s00401-014-1287-x
- By:
- Publication type:
- Article
N-truncated amyloid β (Aβ) 4-42 forms stable aggregates and induces acute and long-lasting behavioral deficits.
- Published in:
- Acta Neuropathologica, 2013, v. 126, n. 2, p. 189, doi. 10.1007/s00401-013-1129-2
- By:
- Publication type:
- Article
Early intraneuronal accumulation and increased aggregation of phosphorylated Abeta in a mouse model of Alzheimer's disease.
- Published in:
- Acta Neuropathologica, 2013, v. 125, n. 5, p. 699, doi. 10.1007/s00401-013-1107-8
- By:
- Publication type:
- Article
Accumulation of intraneuronal Aβ correlates with ApoE4 genotype.
- Published in:
- Acta Neuropathologica, 2010, v. 119, n. 5, p. 555, doi. 10.1007/s00401-010-0666-1
- By:
- Publication type:
- Article
Intraneuronal pyroglutamate-Abeta 3–42 triggers neurodegeneration and lethal neurological deficits in a transgenic mouse model.
- Published in:
- Acta Neuropathologica, 2009, v. 118, n. 4, p. 487, doi. 10.1007/s00401-009-0557-5
- By:
- Publication type:
- Article
APP/PS1KI bigenic mice develop early synaptic deficits and hippocampus atrophy.
- Published in:
- Acta Neuropathologica, 2009, v. 117, n. 6, p. 677, doi. 10.1007/s00401-009-0539-7
- By:
- Publication type:
- Article
Transient intraneuronal Aβ rather than extracellular plaque pathology correlates with neuron loss in the frontal cortex of APP/PS1KI mice.
- Published in:
- Acta Neuropathologica, 2008, v. 116, n. 6, p. 647, doi. 10.1007/s00401-008-0451-6
- By:
- Publication type:
- Article
Axonopathy in an APP/PS1 transgenic mouse model of Alzheimer’s disease.
- Published in:
- Acta Neuropathologica, 2006, v. 111, n. 4, p. 312, doi. 10.1007/s00401-006-0041-4
- By:
- Publication type:
- Article
Amino‐terminally elongated Aβ peptides are generated by the secreted metalloprotease ADAMTS4 and deposit in a subset of Alzheimer's disease brains.
- Published in:
- Neuropathology & Applied Neurobiology, 2024, v. 50, n. 3, p. 1, doi. 10.1111/nan.12991
- By:
- Publication type:
- Article
Meprin β knockout reduces brain Aβ levels and rescues learning and memory impairments in the APP/lon mouse model for Alzheimer’s disease.
- Published in:
- Cellular & Molecular Life Sciences, 2022, v. 79, n. 3, p. 1, doi. 10.1007/s00018-022-04205-5
- By:
- Publication type:
- Article
Intraneuronal APP/Aβ Trafficking and Plaque Formation in β-Amyloid Precursor Protein and Presenilin-1 Transgenic Mice.
- Published in:
- Brain Pathology, 2002, v. 12, n. 3, p. 275, doi. 10.1111/j.1750-3639.2002.tb00442.x
- By:
- Publication type:
- Article
Key Factors in Alzheimer's Disease: β-amyloid Precursor Protein Processing, Metabolism and Intraneuronal Transport.
- Published in:
- Brain Pathology, 2001, v. 11, n. 1, p. 1, doi. 10.1111/j.1750-3639.2001.tb00376.x
- By:
- Publication type:
- Article
Neuron Loss in Transgenic Mouse Models of Alzheimer's Disease.
- Published in:
- International Journal of Alzheimer's Disease, 2010, v. 2010, p. 1, doi. 10.4061/2010/723782
- By:
- Publication type:
- Article
Die modifizierte Amyloid-Hypothese der Alzheimer-Demenz - intraneuronales Abeta induziert Neurodegeneration.
- Published in:
- Neuroforum, 2009, v. 15, n. 3, p. 76, doi. 10.1515/nf-2009-0302
- By:
- Publication type:
- Article
Intracellular Aβ and neuronal death
- Published in:
- 2011
- By:
- Publication type:
- Abstract
Treatment of 5XFAD transgenic mice with Ibuprofen
- Published in:
- 2011
- By:
- Publication type:
- Abstract
P1-038: Inflammatory changes are tightly associated with neurodegeneration in the brain and spinal cord of the APP/PS1KI mouse model of Alzheimer's disease
- Published in:
- 2008
- By:
- Publication type:
- Abstract
P1-026: Intracellular Aβ triggers neuron loss in the cholinergic system of the APP/PS1KI mouse model of Alzheimer's disease
- Published in:
- 2008
- By:
- Publication type:
- Abstract
O3-01-02: Effect of enriched environmental on motor an memory functions in the APP/PS1KI mouse model of Alzheimer's disease
- Published in:
- 2008
- By:
- Publication type:
- Abstract
P1-042: Neuronal loss and changes in metal homeostasis in the APP751<sup>SL</sup>PS1ki mouse model of Alzheimer’s disease
- Published in:
- 2006
- By:
- Publication type:
- Abstract
P1-028: Axonopathy in APP/PS1 transgenic mouse models of Alzheimer’s disease
- Published in:
- 2006
- By:
- Publication type:
- Abstract
O2-04-06: New lessons form the APP/PS1 transgenic mouse model with neuron loss: Metal biology, axonal degeneration and intraneuronal N-modified Aβ aggregation
- Published in:
- 2006
- By:
- Publication type:
- Abstract
P1-042: Neuronal loss and changes in metal homeostasis in the APP751<sup>SL</sup>PS1ki mouse model of Alzheimer’s disease
- Published in:
- 2006
- By:
- Publication type:
- Abstract
P1-028: Axonopathy in APP/PS1 transgenic mouse models of Alzheimer’s disease
- Published in:
- 2006
- By:
- Publication type:
- Abstract
O2-04-06: New lessons form the APP/PS1 transgenic mouse model with neuron loss: Metal biology, axonal degeneration and intraneuronal N-modified Aβ aggregation
- Published in:
- 2006
- By:
- Publication type:
- Abstract
An inhibitory effect on the nuclear accumulation of phospho-STAT1 by its unphosphorylated form.
- Published in:
- Cell Communication & Signaling, 2022, v. 20, n. 1, p. 1, doi. 10.1186/s12964-022-00841-3
- By:
- Publication type:
- Article
Combined long-term enriched environment and caffeine supplementation improve memory function in C57Bl6 mice.
- Published in:
- European Archives of Psychiatry & Clinical Neuroscience, 2023, v. 273, n. 1, p. 269, doi. 10.1007/s00406-022-01431-7
- By:
- Publication type:
- Article
A two-step immunoassay for the simultaneous assessment of Aβ38, Aβ40 and Aβ42 in human blood plasma supports the Aβ42/Aβ40 ratio as a promising biomarker candidate of Alzheimer's disease.
- Published in:
- Alzheimer's Research & Therapy, 2018, v. 10, n. 1, p. N.PAG, doi. 10.1186/s13195-018-0448-x
- By:
- Publication type:
- Article
N-truncated Aβ<sub>4-x</sub> peptides in sporadic Alzheimer's disease cases and transgenic Alzheimer mouse models.
- Published in:
- Alzheimer's Research & Therapy, 2017, v. 9, p. 1, doi. 10.1186/s13195-017-0309-z
- By:
- Publication type:
- Article
Abundance of Aβ<sub>5-x</sub> like immunoreactivity in transgenic 5XFAD, APP/PS1KI and 3xTG mice, sporadic and familial Alzheimer's disease.
- Published in:
- Molecular Neurodegeneration, 2014, v. 9, n. 1, p. 1, doi. 10.1186/1750-1326-9-13
- By:
- Publication type:
- Article
Pyroglutamate Abeta pathology in APP/PS1KI mice, sporadic and familial Alzheimer’s disease cases.
- Published in:
- Journal of Neural Transmission, 2010, v. 117, n. 1, p. 85, doi. 10.1007/s00702-009-0314-x
- By:
- Publication type:
- Article
Circulating immune complexes of Aβ and IgM in plasma of patients with Alzheimer’s disease.
- Published in:
- Journal of Neural Transmission, 2009, v. 116, n. 7, p. 913, doi. 10.1007/s00702-009-0224-y
- By:
- Publication type:
- Article
Effect of copper intake on CSF parameters in patients with mild Alzheimer’s disease: a pilot phase 2 clinical trial.
- Published in:
- Journal of Neural Transmission, 2008, v. 115, n. 12, p. 1651, doi. 10.1007/s00702-008-0136-2
- By:
- Publication type:
- Article
The Cannabinoid CB1/CB2 Agonist WIN55212.2 Promotes Oligodendrocyte Differentiation In Vitro and Neuroprotection During the Cuprizone-Induced Central Nervous System Demyelination.
- Published in:
- CNS Neuroscience & Therapeutics, 2016, v. 22, n. 5, p. 387, doi. 10.1111/cns.12506
- By:
- Publication type:
- Article